Category

• Products3
• Archives2

Organizations

• Bausch + Lomb59
• Eyes On Eyecare41
• Alcon, Inc.37
• American Optometric Association32
• Glaukos25
• Harrow25
• Aldeyra Therapeutics19
• Regeneron19
• Coopervision18
• Sight Sciences18

Tags

• Acquisitions2
• Glaucoma2
• Ocular Hypertension1
• Artificial Tears1
• Dry Eye1
• Dry Eye Disease1
• Eye Drop Solution1
• Eye Drops1
• Ophthalmology1
• Products1

• Organizations: Santen Pharmaceutical✕

Clear all

Products

Bruder to rebrand and distribute Retaine MGD eye drop in the US

The preservative-free drop is expected to hit shelves in early 2025 as Eyeleve MGD.

Products

Visiox Pharma acquires US rights to Omlonti

Santen agrees to sale of prescription-based eye drop indicated for the treatment of glaucoma and ocular hypertension.

Products

Harrow buys North American commercial rights to Santen's ophthalmic brands

Acquisition includes six U.S. and two Canadian products; marks second deal for Harrow this week.

Archives

Is there a new glaucoma medication on the market?— Weekly Glance

A new FDA-approved drug is here!

Archives

Verkazia is now available — Weekly Glance

A new drug for vernal keratoconjunctivitis is on the market.